Dr Lal PathLabs Q3 FY26 results: INR 3.5/share dividend, 4000 ESOP shares allotted

Results RestatedExceptional ItemResults View source PDF Explain this filing

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.3%Reaction day

₹1395.00

prior close

₹1407.40

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.9%-0.6% vs market

Healthcare Service Provider peers, median of 25sector+0.2%+0.1% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.7

15m

-0.8

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.3+0.9-0.6+0.2+0.1

Next day

+2.2-0.8+2.9+0.1+2.1

+0.6+2.1-1.6+2.4-1.8

+0.6+2.9-2.3+2.4-1.8

+1.1+1.8-0.8+3.4-2.3

+3.5+1.5+2.0+4.0-0.5

+3.5+4.6-1.1+4.5-1.0

15d

+0.5+2.1-1.6+2.7-2.2

+0.9-0.3+1.3-5.5+6.5

-6.3-8.6+2.3-10.6+4.3

-1.5+7.0-8.5-2.9+1.4

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr Lal PathLabs Q3 FY26 (Dec 2025) consolidated revenue rose to INR 6,598M from INR 5,967M YoY. 9M revenue up 10.8% at INR 20,602M. Q3 PAT fell 6.8% to INR 914M due to INR 301M one-time Labour Codes charge. Board declared 3rd interim dividend of INR 3.5/share (35%), record date Feb 5. Also allotted 4000 shares under ESOP 2010.

Likely market impact

Q3 profit dipped on one-time Labour Codes charge but 9M revenue and profit grew double digits. Dividend income for shareholders.